Publication | Open Access

Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts

Tumor XenograftsInhibitory EffectsOncologyMedicineHistone Deacetylase InhibitorsAnti-cancer AgentTumor SuppressorProstatic DiseasePharmacologyCell BiologyTumor BiologyCancer Growth